Abstract
OBJECTIVE: To determine the clinical factors before, and in association with, coronary artery bypass grafting (CABG) that increase the risk of readmission to hospital in the first two years after surgery. PATIENTS: All patients in western Sweden who had CABG without simultaneous valve surgery between 1 June 1988 and 1 June 1991. METHODS: All patients who were readmitted to hospital were evaluated by postal inquiry and hospital records. RESULTS: A total of 2121 patients were operated on, of whom 2037 were discharged from hospital. Information regarding readmission was missing in four patients, leaving 2033 patients; 44% were readmitted to hospital. The most common reasons for readmission were angina pectoris and congestive heart failure. There were 12 independent significant predictors for readmission: clinical history (a previous history of either congestive heart failure or myocardial infarction, or CABG); acute operation; postoperative complications (time in intensive care unit greater than two days, neurological complications); clinical findings four to seven days after the operation (arrhythmia, systolic murmur equivalent to mitral regurgitation); medication four to seven days after the operation (antidiabetics, diuretics for heart failure, other antiarrhythmics (other than beta blockers, calcium antagonists, and digitalis), and lack of treatment with aspirin). CONCLUSION: 44% of patients were readmitted to hospital two years after CABG. The most common reasons for readmission were angina pectoris and congestive heart failure. Four clinical markers predicted readmission: clinical history; acute operation status; postoperative complications; and clinical findings and medication four to seven days after operation.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brandrup-Wognsen G., Haglid M., Karlsson T., Berggren H., Herlitz J. Mortality during the two years after coronary artery bypass grafting in relation to perioperative factors and urgency of operation. Eur J Cardiothorac Surg. 1995;9(12):685–691. doi: 10.1016/s1010-7940(05)80126-5. [DOI] [PubMed] [Google Scholar]
- Califf R. M., Harrell F. E., Jr, Lee K. L., Rankin J. S., Hlatky M. A., Mark D. B., Jones R. H., Muhlbaier L. H., Oldham H. N., Jr, Pryor D. B. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA. 1989 Apr 14;261(14):2077–2086. [PubMed] [Google Scholar]
- Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
- Fremes S. E., Goldman B. S., Christakis G. T., Ivanov J., Weisel R. D., Salerno T. A., David T. E. Current risk of coronary bypass for unstable angina. Eur J Cardiothorac Surg. 1991;5(5):235–243. doi: 10.1016/1010-7940(91)90170-o. [DOI] [PubMed] [Google Scholar]
- Grover F. L., Hammermeister K. E., Burchfiel C. Initial report of the Veterans Administration Preoperative Risk Assessment Study for Cardiac Surgery. Ann Thorac Surg. 1990 Jul;50(1):12–28. doi: 10.1016/0003-4975(90)90073-f. [DOI] [PubMed] [Google Scholar]
- Hamilton W. M., Hammermeister K. E., DeRouen T. A., Zia M. S., Dodge H. T. Effect of coronary artery bypass grafting on subsequent hospitalization. Am J Cardiol. 1983 Feb;51(3):353–360. doi: 10.1016/s0002-9149(83)80065-4. [DOI] [PubMed] [Google Scholar]
- Herlitz J., Karlson B. W., Hjalmarson A. Ten-year mortality rate after development of acute myocardial infarction in relation to clinical history and observations during hospital stay: experience from the Göteborg metoprolol trial. Coron Artery Dis. 1993 Dec;4(12):1077–1083. doi: 10.1097/00019501-199312000-00007. [DOI] [PubMed] [Google Scholar]
- Hjalmarson A., Elmfeldt D., Herlitz J., Holmberg S., Málek I., Nyberg G., Rydén L., Swedberg K., Vedin A., Waagstein F. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet. 1981 Oct 17;2(8251):823–827. doi: 10.1016/s0140-6736(81)91101-6. [DOI] [PubMed] [Google Scholar]
- Johnson W. D., Kayser K. L., Hartz A. J., Saedi S. F. Aspirin use and survival after coronary bypass surgery. Am Heart J. 1992 Mar;123(3):603–608. doi: 10.1016/0002-8703(92)90496-i. [DOI] [PubMed] [Google Scholar]
- Lubitz J. D., Gornick M. E., Mentnech R. M., Loop F. D. Rehospitalizations after coronary revascularization among Medicare beneficiaries. Am J Cardiol. 1993 Jul 1;72(1):26–30. doi: 10.1016/0002-9149(93)90213-v. [DOI] [PubMed] [Google Scholar]
- Ridker P. M., Manson J. E., Gaziano J. M., Buring J. E., Hennekens C. H. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. Ann Intern Med. 1991 May 15;114(10):835–839. doi: 10.7326/0003-4819-114-10-835. [DOI] [PubMed] [Google Scholar]
- Smith L. R., Milano C. A., Molter B. S., Elbeery J. R., Sabiston D. C., Jr, Smith P. K. Preoperative determinants of postoperative costs associated with coronary artery bypass graft surgery. Circulation. 1994 Nov;90(5 Pt 2):II124–II128. [PubMed] [Google Scholar]
- Stanton B. A., Jenkins C. D., Goldstein R. L., Vander Salm T. J., Klein M. D., Aucoin R. A. Hospital readmissions among survivors six months after myocardial revascularization. JAMA. 1985 Jun 28;253(24):3568–3573. [PubMed] [Google Scholar]
- Stanton B. A., Jenkins C. D., Goldstein R. L., Vander Salm T. J., Klein M. D., Aucoin R. A. Hospital readmissions among survivors six months after myocardial revascularization. JAMA. 1985 Jun 28;253(24):3568–3573. [PubMed] [Google Scholar]
- Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 1988 Aug 11;319(6):332–337. doi: 10.1056/NEJM198808113190603. [DOI] [PubMed] [Google Scholar]
- Zuanetti G., Latini R., Maggioni A. P., Santoro L., Franzosi M. G. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol. 1993 Dec;22(7):1788–1794. doi: 10.1016/0735-1097(93)90758-s. [DOI] [PubMed] [Google Scholar]
